Elevated risk of venous thromboembolic events in patients with inflammatory myopathies

References

• OsamaOZaidatMDAlanJLernerMDThe Little Black Book of Neurology5th edPhiladelphiaSaunders Elsevier2008
   Google Scholar
• BaerAWortmannRNoninflammatory myopathiesRheum Dis Clin N Am201339457479
   PubMed Web of Science ®Google Scholar
• MastagliaFNeedhamMUpdate on toxic myopathiesCurr Neurol Neurosci Rep201212546121968786
   PubMed Web of Science ®Google Scholar
• PadalaSThompsonPStatins as a possible cause of inflammatory and necrotizing myopathiesAtherosclerosis2012222152122154355
   PubMed Web of Science ®Google Scholar
• GuisSMatteiJBendahanDToxic myopathiesJoint Bone Spine20138023123323238002
   PubMed Web of Science ®Google Scholar
• FinstererJSegallLDrugs interfering with mitochondrial disordersDrug Chem Toxicol20103313819839725
   PubMed Web of Science ®Google Scholar
• OwczarekJJasin´skaMOrszulak-MichalakDDrug-induced myopathies. An overview of the possible mechanismsPharmacol Rep200557233415849374
   PubMed Web of Science ®Google Scholar
• TeenerJInflammatory and toxic myopathySemin Neurol20123249149923677656
   PubMed Web of Science ®Google Scholar
• MohasselPMammenAThe spectrum of statin myopathyCurr Opin Rheumatol20132574775224061077
   PubMed Web of Science ®Google Scholar
• MohasselPMammenAStatin-associated autoimmune myopathy and anti-HMGCR autoantibodiesMuscle Nerve20134847748323519993
   PubMed Web of Science ®Google Scholar
• AbildstromSZRasmussenSRosenMMadsenMTrends in incidence and case fatality rates of acute myocardial infarction in Denmark and SwedenHeart20038950751112695453
   PubMedGoogle Scholar
• EllekjærHHolmenJIndredavikBTerentAEpidemiology of stroke in Innherred, Norway, 1994 to 1996. Incidence and 30-day case-fatality rateStroke199728218021849368561
   PubMed Web of Science ®Google Scholar
• DismukeSEWagnerEHPulmonary embolism as a cause of death. The changing mortality in hospitalized patientsJAMA1986255203920423959287
   PubMed Web of Science ®Google Scholar
• CarsonJLKelleyMADuffAThe clinical course of pulmonary embolismN Engl J Med1992326124012451560799
   PubMed Web of Science ®Google Scholar
• VirchowRThrombose und embolie. Gefässentzündung und septische infektionGesammelte Abhandlungen zur wissenschaftlichen Medicin [Thrombosis and embolism. Vascular inflammation and septic infection. Collected Essays on Scientific Medicine]Frankfurt am MainVon Meidinger & Sohn1856219732 German
   Google Scholar
• NaessIAChristiansenSCRomundstadPCannegieterSCRosendaalFRHammerstrømJIncidence and mortality of venous thrombosis: a populationbased studyJ Thromb Haemost2007569269917367492
   PubMed Web of Science ®Google Scholar
• AndersonFAJrWheelerHBGoldbergRJA population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT StudyArch Intern Med19911519339382025141
   PubMed Web of Science ®Google Scholar
• AgenoWAgnelliGImbertiDMoiaMPalaretiGPistelliRVersoMPrevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the MASTER registryIntern Emerg Med2013857558021660492
   PubMed Web of Science ®Google Scholar
• RumleyAEmbersonJRWannametheeSGLennonLWhincupPHLoweGDEffects of older age on fibrin D-dimer, C-reactive protein and other hemostatic and inflammatory variables in men aged 60–79 yearsJ Thromb Haemost2006498298716689748
   PubMed Web of Science ®Google Scholar
• MariDCoppolaRProvenzanoRHemostasis factors and agingExp Gerontol200843667317869046
   PubMed Web of Science ®Google Scholar
• WhiteRHZhouHMurinSHarveyDEffect of ethnicity and gender on the incidence on venous thromboembolism in a diverse population in California in 1996Thromb Hemost200593298305
   PubMed Web of Science ®Google Scholar
• CohenATAgnelliGAndersonFAVTE Imapct Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortalityThromb Haemost20079875676417938798
   PubMed Web of Science ®Google Scholar
• MolinaJAJiangZGHengBHOngBKVenous thromboembolism at the National Healthcare Group, SingaporeAnn Acad Med Singapore20093847047819565096
   PubMed Web of Science ®Google Scholar
• ZakaiNAMcClureLAJuddSESaffordMMFolsomARLutseyPLCushmanMRacial and regional differences in venous thromboembolism in the United States in 3 cohortsCirculation20141291502150924508826
   PubMed Web of Science ®Google Scholar
• ZakaiNAMcClureLARacial differences in venous thromboembolismJ Thromb Haemost201191877188221797965
   PubMed Web of Science ®Google Scholar
• MismettiPLaporteSDarmonJYBuchmüllerADecoususHMeta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgeryBr J Surg200188913930
   Web of Science ®Google Scholar
• BorgstroemSGreitzTVan der LindenWMolinJRudicsIAnticoagulant prophylaxis of venous thrombosis in patients with fractured neck of the femur; a controlled clinical trial using venous phlebographyActa Chir Scand196512950050814296582
   PubMedGoogle Scholar
• GeertsWHCodeKIJayRMChenESzalaiJPA prospective study of venous thromboembolism after major traumaN Engl J Med1994331160116067969340
   PubMed Web of Science ®Google Scholar
• AcostaJAYangJCWinchellRJSimonsRKFortlageDAHolling-sworth-FridlundPHoytDBLethal injuries and time to death in a level I trauma centerJ Am Coll Surg19981865285339583692
   PubMed Web of Science ®Google Scholar
• O’MalleyKFRossSEPulmonary embolism in major trauma patientsJ Trauma1990307487502352304
   PubMed Web of Science ®Google Scholar
• SamamaMMAn epidemiologic study of risk factors for deep vein thrombosis in medical outpatients. The Sirius StudyArch Intern Med20001603415342011112234
   PubMed Web of Science ®Google Scholar
• ImbertiDAgnelliGAgenoWClinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER RegistryHaematologica20089327327818223291
   PubMed Web of Science ®Google Scholar
• BlomJWDoggenCJOsantoSRosendaalFRMalignancies, pro-thrombotic mutations, and the risk of venous thrombosisJAMA200529371572215701913
   PubMed Web of Science ®Google Scholar
• OttenHMMathijssenJten CateHSoesanMInghelsMRichelDJPrinsMHSymptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenonArch Intern Med200416419019414744843
   PubMed Web of Science ®Google Scholar
• SmeethLCookCThomasSHallAJHubbardRVallancePRisk of deep vein thrombosis and pulmonary embolism after acute infection in a community settingLancet20063671075107916581406
   PubMed Web of Science ®Google Scholar
• van StralenKJRosendaalFRDoggenCJMinor injuries as a risk factor for venous thrombosisArch Intern Med2008168212618195191
   PubMedGoogle Scholar
• StuijverDJvan ZaaneBFeeldersRAIncidence of venous thromboembolism in patients with Cushing’s syndrome: a multicenter cohort studyJ Clin Endocrinol Metab2011963525353221880802
   PubMed Web of Science ®Google Scholar
• SquizzatoARomualdiEPiantanidaESubclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional studyThromb Haemost20079780380617479191
   PubMed Web of Science ®Google Scholar
• LudvigssonJFWelanderALassilaREkbomAMontgomerySMRisk of thromboembolism in 14,000 individuals with coeliac diseaseBr J Haematol200713912112717854316
   PubMed Web of Science ®Google Scholar
• TichelaarYIKluin-NelemansHJMeijerKInfections and inflammatory diseases as risk factors for venous thrombosis. A systematic reviewThromb Haemost201210782783722437808
   PubMed Web of Science ®Google Scholar
• MargaglioneMGrandoneEPopulation genetics of venous thromboembolism. A narrative reviewThromb Haemost201110522123120941456
   PubMed Web of Science ®Google Scholar
• MorangePETrégouëtDACurrent knowledge on the genetics of incident venous thrombosisJ Thromb Haemost201311Suppl 111112123809115
   PubMedGoogle Scholar
• AgenoWBecattiniCBrightonTSelbyRKamphuisenPWCardiovascular risk factors and venous thromboembolism: a meta-analysisCirculation20081179310218086925
   PubMed Web of Science ®Google Scholar
• ReitsmaPHVersteegHHMiddeldorpSMechanistic view of risk factors for venous thromboembolismArterioscler Thromb Vasc Biol20123256356822345594
   PubMed Web of Science ®Google Scholar
• LaiYTDaiYSYenMFDermatomyositis is associated with an increased risk of cardiovascular and cerebrovascular events: a Taiwan-ese population-based longitudinal follow-up studyBr J Dermatol20131681054105923330740
   PubMed Web of Science ®Google Scholar
• TisseverasingheABernatskySPineauCAArterial events in persons with dermatomyositis and polymyositisJ Rheumatol2009361943194619648306
   PubMed Web of Science ®Google Scholar
• CarruthersECChoiHKSayreECRisk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based studyAnn Rheum Dis201675111011625193998
   PubMed Web of Science ®Google Scholar
• XuJLupuFEsmonCTInflammation, innate immunity and blood coagulationHamostaseologie201030568920162248
   PubMed Web of Science ®Google Scholar
• ZollerBLiXSundquistJRisk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from SwedenLancet201237924424922119579
   PubMed Web of Science ®Google Scholar
• RamagopalanSVWottonCJHandelAERisk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage studyBMC Med20119121219637
   PubMed Web of Science ®Google Scholar
• JohannesdottirSASchmidtMHorvath-PuhoEAutoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case-control studyJ Thromb Haemost2012108152122353382
   PubMed Web of Science ®Google Scholar
• Selva-O’CallaghanAFernandez-LuqueAMartinez-GomezXVenous thromboembolism in patients with dermatomyositis and polymyositisClin Exp Rheumatol20112984684921962007
   PubMed Web of Science ®Google Scholar
• IaccarinoLBartoloniEGerliRDrugs in induction and treatment of idiopathic inflammatory myopathiesAuto Immun Highlights201459510026000161
   PubMedGoogle Scholar
• MarieIMorbidity and mortality in adult polymyositis and dermatomyositisCurr Rheumatol Rep20121427528522410829
   PubMed Web of Science ®Google Scholar
• OddisCVMedsgerTAJrRelationship between serum creatine kinase level and corticosteroid therapy in polymyositisdermatomyositisJ Rheumatol1988158078113172094
   PubMed Web of Science ®Google Scholar
• VenalisPLundbergIEImmune mechanisms in polymyositis and dermatomyositis and potential targets for therapyRheumatology (Oxford)20145339740523970542
   PubMed Web of Science ®Google Scholar
• CoudercMGottenbergJEMarietteXEfficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registryRheumatology (Oxford)2011502283228922019807
   PubMed Web of Science ®Google Scholar
• Ramos-CasalsMGarcía-HernándezFJde RamónEOff-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseasesClin Exp Rheumatol20102846847620525449
   PubMed Web of Science ®Google Scholar
• NalottoLIaccarinoLZenMRituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literatureImmunol Res20135636237023572427
   PubMed Web of Science ®Google Scholar
• DalakasMCRakocevicGSchmidtJEffect of alemtuzumab (CAMPATH1-H) in patients with inclusion-body myositisBrain20091321536154419454532
   PubMed Web of Science ®Google Scholar
• WłodarczykMSobolewskaAFichnaJWiśniewska-JarosińskaMPrevention and therapeutic strategies of thromboembolic events in patients with inflammatory bowel diseases: a report of three casesCurr Drug Targets201516319419825382207
   PubMed Web of Science ®Google Scholar
• PapaAGerardiVMarzoMFeliceCRapacciniGLGasbarriniAVenous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatmentWorld J Gastroenterol2014203173317924695669
   PubMed Web of Science ®Google Scholar
• FumeryMXiaocangCDauchetLGower-RousseauCPeyrin-BirouletLColombelJFThromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a metaanalysis of observational studiesJ Crohns Colitis2014846947924183231
   PubMed Web of Science ®Google Scholar
• DaneseSPapaASaibeniSRepiciAMalesciAVecchiMInflammation and coagulation in inflammatory bowel disease: the clot thickensAm J Gastroenterol200710217418617100967
   PubMed Web of Science ®Google Scholar
• MagroFSoaresJBFernandesDVenous thrombosis and prothrombotic factors in inflammatory bowel diseaseWorld J Gastroenterol2014204857487224803797
   PubMed Web of Science ®Google Scholar
• FrankRDAltenwerthBBrandenburgVMNolden-KochMBlockFEffect of intravenous high-dose methylprednisolone on coagulation and fibrinolysis markersThromb Haemost20059446746816116692
   PubMedGoogle Scholar
• PanditHBSpillertCREffect of methylprednisolone on coagulationJ Natl Med Assoc19999145345612656434
   PubMed Web of Science ®Google Scholar
• TanVPChungAYanBPGibsonPRVenous and arterial disease in inflammatory bowel diseaseJ Gastroenterol Hepatol2013281095111323662785
   PubMed Web of Science ®Google Scholar
• SamJJBernsteinCNRazikRThanabalanRNguyenGCPhysicians’ perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel diseaseDig Dis Sci201358465223053902
   PubMedGoogle Scholar
• NguyenGCBernsteinCNBittonAConsensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of GastroenterologyGastroenterology201414683584824462530
   PubMed Web of Science ®Google Scholar
• BernatskySPanopalisPPineauCAHealthcare costs of inflammatory myopathiesJ Rheumatol20113888588821362757
   PubMed Web of Science ®Google Scholar